Caroline Young - 13 Jun 2024 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Caroline Young by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
13 Jun 2024
Net transactions value
+$518
Form type
4
Filing time
02 Jul 2024, 17:33:45 UTC
Previous filing
30 Jan 2025
Next filing
02 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $38 +25 +0.09% $1.52 26,726 13 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $72 +48 +0.18% $1.50 26,774 14 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $61.09 +41 +0.15% $1.49 26,815 17 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $64.37 +41 +0.15% $1.57 26,856 18 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $62.73 +41 +0.15% $1.53 26,897 20 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $61.09 +41 +0.15% $1.49 26,938 21 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $33.39 +21 +0.08% $1.59 26,959 24 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $32.34 +21 +0.08% $1.54 26,980 25 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $31.5 +21 +0.08% $1.50 27,001 26 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $31.92 +21 +0.08% $1.52 27,022 27 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $30 +20 +0.07% $1.50 27,042 28 Jun 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.